Aspirion Pitches AI Tool to Find Patterns Behind Clinical Denials
In a Becker's Hospital Review piece, Aspirion executives argue that hospitals focused only on overturning individual clinical denials miss the recurring patterns driving them, and promote the company's AI-enabled "ClinIQ" platform as a solution. The piece cites Kodiak Solutions data showing revenue leakage across more than 2,300 hospitals rose about 25% in 2025 to $48.4 billion, driven partly by clinical denials tied to medical necessity, and a survey finding 76% of revenue cycle leaders expect denial rates to keep rising. Aspirion frames denials as falling into two categories, payer behavior versus provider documentation gaps, and says its tool helps health systems distinguish the two at scale and route insights to CDI, utilization management, and managed care teams. Aspirion reports its clients see appeals filed 2.2 times faster and a 64% resolution rate using this approach.
Hospitals and health systems face a growing, costly volume of clinical denials, and vendor claims about AI-driven pattern analysis speak directly to revenue cycle leaders' bottom-line exposure from unresolved documentation and payer disputes.
Finance · Managed Care
You might also like